Navigation Links
Important Data Presented on Independent Predictors of Mortality in Patients With Idiopathic Pulmonary Fibrosis
Date:5/17/2009

InterMune, said, "We view the results of this study as clinically important and supportive of the results from our Phase 3 CAPACITY program, in which the primary endpoint was change in percent predicted FVC."

The analysis in the du Bois study employed longitudinal data from two large prospective clinical trials in patients with IPF. A total of 1,099 well-characterized patients who participated in the GIPF-001 and GIPF-007 (INSPIRE) trials were included in the analysis. In addition to a comprehensive multivariate model that considered all potential predictors of one-year mortality, researchers developed a practical model based on widely available and reliable measures, including FVC change, that can be used in the clinical setting to assess the near-term risk of death in patients with IPF. Dr. du Bois added, "What the practicing clinician needs is an index that is simple to apply in the office and that predicts likely outcome for an individual patient over the short term. To be able to add this information into the risk/benefit equation for that individual patient will allow a more informed management strategy to be defined. This study has provided such an index."

About the CAPACITY Program

InterMune has reported the results of two concurrent, randomized, double-blind, placebo controlled, Phase 3 trials, known as CAPACITY 1 and CAPACITY 2, evaluating the safety and efficacy of pirfenidone for the treatment of patients with IPF. In CAPACITY 2, treatment with pirfenidone resulted in a statistically and clinically significant reduction in the loss of forced vital capacity (FVC) and increase in progression-free survival time. In CAPACITY 1, the difference between pirfenidone and placebo in FVC change at week 72 was not statistically significant; however, the overall results were consistent with those of CAPACITY 2, suggesting a treatment benefit. Treatment with pirfenidone was safe and generally well tolerated;
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. CMSA Delivers Important Message to Congress: Case Management Services Improve Patient Care and Should Be Key Strategy in Health Care Reform Initiatives
2. What Motivates Physicians to Succeed? Money Isn't Most Important
3. Major statin study reveals several important findings for reducing prostate cancer and disease
4. Leapfrog Group Hospital Survey Finds Majority of Hospitals Fail to Meet Important Quality Standards
5. New Research Shows Tree Nuts May Play an Important Role in the Health of People With Diabetes
6. UT Southwestern researchers reveal how the brain processes important information
7. Nu Skin Charitable Promotion Reaches Important Milestone: 100,000 Trees Donated to African Nation of Malawi
8. AUDIO from Medialink and Mens Health Network: Important Decision Regarding Prostate Cancer
9. Penn researchers identify new protein important in breast cancer genes role in DNA repair
10. Important new model shows how proteins find the right DNA sequences
11. Why Blood and Bone Marrow Donors Are So Important: Extreme Makeover: Home Edition Profiles Blood Drive Honoree Lizzie Bell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... “ Pokemini ” was featured on NewsWatch as part ... mobile applications on the iOS, Android, and Windows markets. Mallory ... the app review and shared with viewers how this is ... couple of years, mobile games have benefited from building in ... Crush allows users to connect their games to Facebook, see ...
(Date:3/6/2015)... Village, CO (PRWEB) March 06, 2015 ... infant mortality around the world is traveling to Angola, ... with survivors of their malnutrition program. , This will ... same region in Angola, demonstrating their commitment to the ... and under. The team will engage with the mothers ...
(Date:3/6/2015)... March 06, 2015 Ticket Down is a ... Oregon at the Moda Center. After being away ... Brooks is showing no signs of letting up on his ... legend and his wife, Trisha Yearwood, to venues around the ... bringing their critically acclaimed tour to the Moda Center in ...
(Date:3/6/2015)... March 06, 2015 Follow us ... the pharmacokinetics of a drug refers to testing of ... inside an organism. When toxicity studies are clubbed together ... or ADME/Tox. Increasing focus on lowering costs and time ... testing worldwide. The traditional drug development model uses toxicity ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 As the ... healthcare services programs, the organization has hired two new ... Ph.D. They will report to Grace Pavlath, Ph.D, ... President and Scientific Program Director, and together will lead ... to treatments and cures for various types of neuromuscular ...
Breaking Medicine News(10 mins):Health News:A Kawaii Social Game was Featured on NewsWatch Television on February 26, 2015 2Health News:Saving Moses Returns to Angola to Continue Giving Infants and Children a Chance to Live 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4
... health issues; company teams with fitness expert Denise Austin to launch ... ... living,longer and leading more active lives than their parents, yet still have,room ... by Energizer Holdings, Inc. (NYSE: ENR ), nearly two-thirds,(64 percent) of ...
... The Procter &,Gamble Company (NYSE: PG ) announced ... the quarter. Sales were up behind strong volume growth,from ... in developing regions. Organic volume increased six percent and,organic ... earnings per,share increased 17 percent to $0.98 per share, ...
... Education, KIRKLAND, Wash., Jan. 31 In ... want to keep. But these,seasoned people may leave ... taking,time off. Why? "A large percentage have aging ... needing constant attention," says Mario Sestito,Director of Business ...
... arthritis (RA), an inflammatory autoimmune disease, tend to ... One explanation for this increasingly recognized fact ... of inflammation, elevation of the C-reactive protein (CRP) ... the general population. However, other highly inflammatory ...
... build to dangerous levels in body and cause autism, ... -- The latest chapter in the debate over whether ... release of a study that showed the controversial mercury-containing ... can,t build up to toxic levels. , "Thimerosal has ...
... The Department of,Labor,s Occupational Safety and Health Administration ... are being accepted for,persons to serve on the ... committee was established under section 7(a) of the,Occupational ... the Secretary of Labor,and the Secretary of Health ...
Cached Medicine News:Health News:Boomers: Feeling Young or Fooling Themselves? 2Health News:Boomers: Feeling Young or Fooling Themselves? 3Health News:Boomers: Feeling Young or Fooling Themselves? 4Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 2Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 3Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 4Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 5Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 6Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 7Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 8Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 9Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 10Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 11Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 12Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 13Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 14Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 15Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 16Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 17Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 18Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 19Health News:Protecting Productivity at the Worksite in Challenging Times 2Health News:The HLA-DRB1 gene and premature death in rheumatoid arthritis 2Health News:The HLA-DRB1 gene and premature death in rheumatoid arthritis 3Health News:Mercury in Childhood Vaccines Excreted Quickly 2Health News:Mercury in Childhood Vaccines Excreted Quickly 3Health News:Mercury in Childhood Vaccines Excreted Quickly 4Health News:OSHA Seeking Nominations for National Advisory Committee on Occupational Safety and Health 2
(Date:3/5/2015)... , March 5, 2015  BioPhotas, Inc., an ... that use patented photo-therapeutic technologies to treat skin, muscle ... with the Semper Fi Fund to provide BioPhotas, flagship ... need of pain management solutions.  Commenting ... first Marine who used the Celluma at the Warrior ...
(Date:3/5/2015)...   ndd Medical Technologies , a leader in ... ultrasound technology, announced that its EasyOne Pro® was used ... Antonio Pulmonary Fibrosis Support Group. The clinic targeted patients ... as well as those suspected of having ILD or ... 12 square inches, EasyOne Pro provides accurate respiratory test ...
(Date:3/5/2015)... , March 5, 2015  AMRI (NASDAQ: ... , fills the newly created position of VP of ... Conway , Senior Vice President of Global Sales and ... will lead the international sales team in an effort ... in targeted market segments. Mr. Pettersson will drive strategy ...
Breaking Medicine Technology:BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 3AMRI Hires VP of International Sales 2
... long-term anemia and organ damage in mice and paves the ... MEMPHIS, Tenn., Dec. 3 Using a harmless ... scientists at St. Jude Children,s Research Hospital have alleviated sickle ... the treated mice showed essentially no difference from normal mice. ...
... Isogen, a contract development and,manufacturing organization for sterile filling, ... it expand operations to meet the global,biopharma demand for ... Isogen has previously announced a successful first round series ... line facility in Q1 2009 to,deliver on the previously ...
Cached Medicine Technology:Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3
The CRW system is the premier stereotactic system. The CRW system can be configured as a basic CT-only system, a CT/MR scanner-dependent system, or a high-level CT/MR scanner-independent system with ...
... The basic frame, consisting of one part only, ... fixations of highly compressed Polyamide may be rotated ... to all head sizes and shapes, as well. ... frame far enough in caudal direction, which is ...
VG1 ALIF (Anterior Lateral) Anterior lumbar interbody fusion. Frozen freeze-dried preservation....
Allograft implants can be easily used to repair and promote the healing of a wide variety of bone and other tissue defects....
Medicine Products: